PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

oleh: X.-N. Gao, X. Lou, J. Lin, Y.-F. Su, J. Wang, L. Xu, H. Yu, A. Wang, Y.-Z. Wang, D.-H. Liu

Format: Article
Diterbitkan: Wiley 2022-06-01

Deskripsi

No description available for this item.